Peptomyc steps forward as a Clinical Stage Biotech company

Barcelona, Spain, December 21st, 2020 – Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics for cancer treatment, announces that it has officially transitioned from pre-clinical to Clinical Stage, having filed its first Clinical Trial Application in Europe. The company has recently completed the pre-clinical safety studies for its first-in-class … Continue reading Peptomyc steps forward as a Clinical Stage Biotech company